Physician profile
Dora H Hilty
NPI 1194797431
$5,705.62
in general payments reported to CMS, 2019-2025
42 companies · $1,162 in 2025
The $1,162 reported for 2025 was more than what 87% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2020: $149 · 2021: $432 · 2022: $1,106 · 2023: $1,331 · 2024: $1,413 · 2025: $1,162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,883 · Consulting Fee: $23.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,882.97 |
| Consulting Fee | $23.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,535.95 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $590.15 | 2020-2025 | Airsupra, Farxiga, Breztri |
| Lilly USA, LLC | $465.72 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $298.94 | 2019-2025 | |
| Amgen INC. | $259.31 | 2020-2025 | Evenity, Prolia, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $250.41 | 2019-2025 | Jardiance |
| Vanda Pharmaceuticals INC. | $238.82 | 2021-2023 | Hetlioz, Fanapt |
| Glaxosmithkline, LLC. | $213.26 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Bayer Healthcare Pharmaceuticals INC. | $207.99 | 2022-2025 | |
| Abbott Laboratories | $200.84 | 2021-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Novartis Pharmaceuticals Corporation | $169.77 | 2019-2023 | |
| Novo Nordisk INC | $144.16 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Astellas Pharma US INC | $98.08 | 2020-2025 | Veozah |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $92.56 | 2023-2025 | Xifaxan, Trulance |
| Biohaven Pharmaceutical Holding Company LTD. | $85.25 | 2022 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $67.89 | 2023-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $53.64 | 2021-2025 | Gardasil 9, Vaxneuvance, Capvaxive |
| Eisai INC. | $51.61 | 2021-2025 | |
| Sanofi Pasteur INC. | $49.23 | 2022-2023 | |
| Dexcom, INC. | $44.04 | 2024-2025 | Dexcom G6 Transmitter |
| Sumitomo Pharma America, INC. | $43.90 | 2024 | Gemtesa |
| Edwards Lifesciences Corporation | $42.83 | 2022-2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Otsuka America Pharmaceutical, INC. | $40.59 | 2024-2025 | Rexulti |
| Janssen Pharmaceuticals, INC | $39.68 | 2020-2025 | Spravato |
| Allergan, INC. | $37.15 | 2019-2020 | |
| Cranial Technologies, INC | $36.49 | 2025 | Doc Band |
| Nestle Healthcare Nutrition INC. | $36.49 | 2021-2022 | |
| Insightec,INC | $34.52 | 2023 | Exablate |
| Corium, LLC | $33.17 | 2023-2024 | Azstarys |
| Baxter Healthcare | $27.08 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $26.25 | 2024 | Austedo Xr |
| Echosens North America, INC. | $23.00 | 2023 | Fibroscan |
| Esperion Therapeutics, INC. | $22.36 | 2021 | |
| Aimmune Therapeutics, INC. | $20.58 | 2025 | Zenpep |
| Amarin Pharma, INC. | $19.46 | 2022 | |
| Gilead Sciences, INC. | $18.14 | 2020 | |
| Grifols USA, LLC | $17.07 | 2019 | |
| Medtronic, INC. | $15.61 | 2025 | Inceptiv |
| Philips North America LLC | $15.48 | 2024 | (Ck7) Extended Holter |
| Daiichi Sankyo INC. | $15.25 | 2021 | |
| Lundbeck LLC | $13.48 | 2022 | |
| Ossur Americas, INC. | $9.42 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dora Hilty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.